{"denomUnitsSelected":"Participants","description":"OS is defined as the time from the date of the first dose administration of any study drug to the documentation of death due to any cause. OS will be assessed by the investigator as per IMWG criteria.","reportingStatus":"NOT_POSTED","timeFrame":"Up to 15.9 months","title":"Phase 1 and Phase 2a: Overall Survival (OS)","type":"SECONDARY"}